1: Stewart RJ, Fredenburgh JC, Leslie BA, Keyt BA, Rischke JA, Weitz JI. Related Articles, Links
Identification of the mechanism responsible for the increased fibrin specificity of TNK-tissue plasminogen activator relative to tissue plasminogen activator.
J Biol Chem. 2000 Apr 7;275(14):10112-20.
PMID: 10744692 [PubMed - indexed for MEDLINE]
2: Verstraete M. Related Articles, Links
Newer thrombolytic agents.
Ann Acad Med Singapore. 1999 May;28(3):424-33. Review.
PMID: 10575530 [PubMed - indexed for MEDLINE]
3: Field M, Papac D, Jones A. Related Articles, Links
The use of high-performance anion-exchange chromatography and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry to monitor and identify oligosaccharide degradation.
Anal Biochem. 1996 Jul 15;239(1):92-8.
PMID: 8660630 [PubMed - indexed for MEDLINE]
4: De Bruyn VH, Bergmann R, Keyt BA, Bennett WF, Sobel BE. Related Articles, Links
Scintigraphic visualization of pulmonary thrombi with 123I-YPACK-TNK-tPA.
Coron Artery Dis. 1995 Sep;6(9):715-21.
PMID: 8747877 [PubMed - indexed for MEDLINE]
5: Collen D, Stassen JM, Yasuda T, Refino C, Paoni N, Keyt B, Roskams T, Guerrero JL, Lijnen HR, Gold HK, et al. Related Articles, Links
Comparative thrombolytic properties of tissue-type plasminogen activator and of a plasminogen activator inhibitor-1-resistant glycosylation variant, in a combined arterial and venous thrombosis model in the dog.
Thromb Haemost. 1994 Jul;72(1):98-104.
PMID: 7974384 [PubMed - indexed for MEDLINE]
Time used: 16 miliseconds.

Webpage designed by Dr. Xueliang Fang, last updated on 3/10/2005